Details
Stereochemistry | ACHIRAL |
Molecular Formula | NO2.Na |
Molecular Weight | 68.9953 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[O-]N=O
InChI
InChIKey=LPXPTNMVRIOKMN-UHFFFAOYSA-M
InChI=1S/HNO2.Na/c2-1-3;/h(H,2,3);/q;+1/p-1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | NO2 |
Molecular Weight | 46.0055 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16865769 | https://www.ncbi.nlm.nih.gov/pubmed/24843165 | https://www.ncbi.nlm.nih.gov/pubmed/21570835 | https://www.drugs.com/international/sodium-nitrite.html
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16865769 | https://www.ncbi.nlm.nih.gov/pubmed/24843165 | https://www.ncbi.nlm.nih.gov/pubmed/21570835 | https://www.drugs.com/international/sodium-nitrite.html
Nitrite Ion is a symmetric anion with equal NāO bond lengths. Nitrite is important in biochemistry as a source of the potent vasodilator nitric oxide. Nitrate or nitrite (ingested) under conditions that result in endogenous nitrosation has been classified as "Probably carcinogenic to humans" (Group 2A) by International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization (WHO) of the United Nations. Sodium nitrite is used for the curing of meat because it prevents bacterial growth and, as it is a reducing agent (opposite of oxidation agent), in a reaction with the meat's myoglobin, gives the product a desirable pink-red "fresh" color, such as with corned beef. This use of nitrite goes back to the Middle Ages, and in the US has been formally used since 1925. Because of the relatively high toxicity of nitrite (the lethal dose in humans is about 22 milligrams per kilogram of body weight), the maximum allowed nitrite concentration in meat products is 200 ppm. At these levels, some 80 to 90% of the nitrite in the average U.S. diet is not from cured meat products, but from natural nitrite production from vegetable nitrate intake. Under certain conditions ā especially during cooking ā nitrites in meat can react with degradation products of amino acids, forming nitrosamines, which are known carcinogens. However, the role of nitrites (and to some extent nitrates) in preventing botulism by preventing C. botulinum endospores from germinating have prevented the complete removal of nitrites from cured meat, and indeed by definition in the U.S., meat cannot be labeled as "cured" without nitrite addition. They are considered irreplaceable in the prevention of botulinum poisoning from consumption of cured dry sausages by preventing spore germination. Nitrite is a member of the drug class antidotes and is used to treat Cyanide Poisoning.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL261 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21570835 |
8.4 mM [Ki] | ||
Target ID: CHEMBL3025 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21208801 |
0.82 mM [Ki] | ||
Target ID: CHEMBL2111457 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15501038 |
16.0 mM [Ki] | ||
Target ID: CHEMBL2326 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16621537 |
1.78 mM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Sodium Nitrite Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Nitrate reductase from Achromobacter fischeri; purification and properties: function of flavines and cytochrome. | 1957 Mar |
|
A triphosphopyridine nucleotide-specific nitrite reductase from Escherichia coli. | 1961 Dec |
|
Proton translocation and the respiratory nitrate reductase of Escherichia coli. | 1975 Dec |
|
Catalysis of nitrosyl transfer reactions by a dissimilatory nitrite reductase (cytochrome c,d1). | 1984 Feb 25 |
|
The assimilatory nitrate reductase from the phototrophic bacterium, Rhodobacter capsulatus E1F1, is a flavoprotein. | 1997 Sep 1 |
|
Structure of cytochrome c nitrite reductase. | 1999 Jul 29 |
|
The presence of 4-hydroxyphenylacetic acid in human saliva and the possibility of its nitration by salivary nitrite in the stomach. | 2002 May 8 |
|
Crystal structure of a NO-forming nitrite reductase mutant: an analog of a transition state in enzymatic reaction. | 2003 Mar 14 |
|
Simultaneous determination of nitrate and nitrite in biological fluids by capillary electrophoresis and preliminary study on their determination by microchip capillary electrophoresis. | 2004 Oct 8 |
|
Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. | 2005 Aug |
Sample Use Guides
Sodium Nitrite -10 mL of sodium nitrite at the rate of 2.5 to 5 mL/minute
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27214747
Erythrocytes, at 10% hematocrit, were treated with 0.1ā10mM NaNO2 (corresponding to 0.0046ā0.46mg/mL nitrite) for 30 min at 37_C. NaNO2 stock solutions were prepared in PBS. Cells not treated with NaNO2 were similarly incubated at 37_C and served as control. After 30-min incubation, samples were centrifuged at 2,500 rpm for 10min at 4C and the pellets were washed with PBS. Erythrocytes in pellets were then lysed by adding 10 volumes of 5mMsodium phosphate buffer, pH 7.4, and allowed to stand for 2 h at 4C. Supernatants (hemolysates) obtained after centrifugation of the samples at 3,000 rpm were either used immediately or quickly frozen in aliquots and analyzed later. Hemoglobin concentration in hemolysates was determined by Drabkinās reagent using a kit from Crest Biosystems
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:43:46 GMT 2023
by
admin
on
Fri Dec 15 15:43:46 GMT 2023
|
Record UNII |
M0KG633D4F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
729719
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
232506
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
WHO-VATC |
QV03AB08
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
4.2
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
CFR |
21 CFR 250.102
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
244207
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
233306
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
CFR |
21 CFR 172.175
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
359111
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
252707
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
288209
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
238707
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
WHO-ATC |
V03AB08
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
233806
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-250
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
225606
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
EPA PESTICIDE CODE |
76204
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
239207
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
CFR |
21 CFR 176.170
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
CFR |
21 CFR 172.177
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 1113
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/13/1224
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
JECFA EVALUATION |
INS-250
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
495615
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
||
|
FDA ORPHAN DRUG |
233906
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9894
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | RxNorm | ||
|
SODIUM NITRITE
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | Description: A white to slightly yellow, granular powder, or white or almost white, opaque, fused masses or sticks; odourless. Solubility: Freely soluble in water; sparingly soluble in ethanol (~750 g/l) TS. Category: Vasodilator. Storage: Sodium nitrite should be kept in a well-closed container, protected from light. Additional information: Sodium nitrite is deliquescent in air. Even in the absence of light, it is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Definition: Sodium nitrite contains not less than 98.0% and not more than 100.5% of NaNO2, calculated with reference to the dried substance. | ||
|
4797
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
E 250
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
757
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
CHEMBL1161681
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
1614454
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
SODIUM NITRITE
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
M0KG633D4F
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
m10049
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | Merck Index | ||
|
77391
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
D012977
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
100000078118
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
SUB15308MIG
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
7632-00-0
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
DB09112
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
DTXSID0020941
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
M0KG633D4F
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
231-555-9
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
78870
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY | |||
|
23668193
Created by
admin on Fri Dec 15 15:43:46 GMT 2023 , Edited by admin on Fri Dec 15 15:43:46 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
LABELED -> NON-LABELED |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |